Company profile
IMV Inc.
OTC: IMVIF · Healthcare · Biotechnology
Canadian filerHQ Dartmouth, NSCIK 0001734768Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 43
v0.1 · 5/100 weight · pillars only
↑ listing tenure, workforce scale · ↓ Piotroski F, filing timeliness
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$38.0M
Employees
63
as of 2026-08-29
Market cap
$23.4k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$38.0M-$38.0M2022
Total assets$31.3M$31.3M2022
Liabilities$38.0M$38.0M2022
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is IMV Inc.’s financial profile?
IMV Inc. earned -$38.0M in FY2022 net income.
Peers · Healthcare
Western Sierra Resource Corporation——Next Generation Management Corp.——MedSmart Group Inc.——Ocean Biomedical, Inc.——MabCure Inc.——Parallel Industries Inc.——Key facts
CEOAndrew Hall
SectorHealthcare
IndustryBiotechnology
HeadquartersDartmouth, NS
ExchangeOTC: IMVIF
Employees63
IPO date2013-04-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.